Pedro A Cohen

Title: Pedro A. Cohen: Innovator in Fusion Polypeptide Technology

Introduction

Pedro A. Cohen is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the area of fusion polypeptides. With a total of 2 patents to his name, Cohen's work has the potential to impact various applications in medicine and research.

Latest Patents

Cohen's latest patents focus on the expression of fusion polypeptides transported out of the cytoplasm. The invention is directed to the use of a fusion partner that does not contain a leader sequence, as a means to increase the solubility and activity of recombinant polypeptides. This innovation facilitates the expression of fusion proteins, which are then transported out of the cytoplasm. The invention includes a nucleic acid encoding a fusion polypeptide comprising a mature interleukin-1-like polypeptide or a leader-deleted-translocating polypeptide, along with a polypeptide of interest. Additionally, it encompasses host cells comprising such nucleic acids and fusion proteins so encoded. The invention also includes methods for using these nucleic acids to produce recombinant fusion polypeptides, mature polypeptides of interest, and purified compositions thereof.

Career Highlights

Pedro A. Cohen is currently associated with Celtrix Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the biotechnology sector.

Collaborations

Cohen has collaborated with notable colleagues, including Desmond D. Mascarenhas and Yang Zhang. These collaborations have likely contributed to the innovative advancements in his research.

Conclusion

Pedro A. Cohen's contributions to the field of fusion polypeptides demonstrate his commitment to advancing biotechnology. His innovative patents and collaborations highlight his role as a significant inventor in this area.